Matinas BioPharma Holdings, Inc. Quarterly Debt-to-equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Matinas BioPharma Holdings, Inc. quarterly Debt-to-equity history and growth rate from Q3 2014 to Q3 2024.
  • Matinas BioPharma Holdings, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 30.5 %, a 37.9% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 30.5 +8.39 +37.9% Sep 30, 2024
Q2 2024 30 +8.69 +40.8% Jun 30, 2024
Q1 2024 28 +6.53 +30.5% Mar 31, 2024
Q4 2023 23.6 +2.65 +12.6% Dec 31, 2023
Q3 2023 22.1 +2.64 +13.5% Sep 30, 2023
Q2 2023 21.3 +3.8 +21.7% Jun 30, 2023
Q1 2023 21.4 +6.65 +45% Mar 31, 2023
Q4 2022 21 +8.31 +65.6% Dec 31, 2022
Q3 2022 19.5 +8.04 +70.1% Sep 30, 2022
Q2 2022 17.5 +7.29 +71.4% Jun 30, 2022
Q1 2022 14.8 +5.25 +55% Mar 31, 2022
Q4 2021 12.7 +3.24 +34.4% Dec 31, 2021
Q3 2021 11.5 +0.91 +8.62% Sep 30, 2021
Q2 2021 10.2 -1.89 -15.6% Jun 30, 2021
Q1 2021 9.54 -5.44 -36.3% Mar 31, 2021
Q4 2020 9.42 -9.6 -50.5% Dec 31, 2020
Q3 2020 10.6 -8.35 -44.2% Sep 30, 2020
Q2 2020 12.1 -9.09 -42.9% Jun 30, 2020
Q1 2020 15 -8.19 -35.3% Mar 31, 2020
Q4 2019 19 -11.5 -37.7% Dec 31, 2019
Q3 2019 18.9 -15.5 -45% Sep 30, 2019
Q2 2019 21.2 -10.5 -33% Jun 30, 2019
Q1 2019 23.2 -4.69 -16.8% Mar 31, 2019
Q4 2018 30.6 +7.54 +32.8% Dec 31, 2018
Q3 2018 34.4 +11.9 +52.6% Sep 30, 2018
Q2 2018 31.6 +9.58 +43.4% Jun 30, 2018
Q1 2018 27.9 -1.26 -4.33% Mar 31, 2018
Q4 2017 23 -21.8 -48.6% Dec 31, 2017
Q3 2017 22.5 -23 -50.5% Sep 30, 2017
Q2 2017 22.1 -29 -56.8% Jun 30, 2017
Q1 2017 29.1 -13.4 -31.5% Mar 31, 2017
Q4 2016 44.8 +2.45 +5.79% Dec 31, 2016
Q3 2016 45.5 +1.37 +3.11% Sep 30, 2016
Q2 2016 51 +11 +27.3% Jun 30, 2016
Q1 2016 42.5 +9.77 +29.9% Mar 31, 2016
Q4 2015 42.3 +25.1 +146% Dec 31, 2015
Q3 2015 44.1 +32.5 +279% Sep 30, 2015
Q2 2015 40.1 Jun 30, 2015
Q1 2015 32.7 Mar 31, 2015
Q4 2014 17.2 Dec 31, 2014
Q3 2014 11.6 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.